rs5707

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000537.4(REN):​c.492+17T>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.239 in 1,564,664 control chromosomes in the GnomAD database, including 46,173 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.25 ( 4947 hom., cov: 32)
Exomes 𝑓: 0.24 ( 41226 hom. )

Consequence

REN
NM_000537.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0520

Publications

30 publications found
Variant links:
Genes affected
REN (HGNC:9958): (renin) This gene encodes renin, an aspartic protease that is secreted by the kidneys. Renin is a part of the renin-angiotensin-aldosterone system involved in regulation of blood pressure, and electrolyte balance. This enzyme catalyzes the first step in the activation pathway of angiotensinogen by cleaving angiotensinogen to form angiotensin I, which is then converted to angiotensin II by angiotensin I converting enzyme. This cascade can result in aldosterone release, narrowing of blood vessels, and increase in blood pressure as angiotension II is a vasoconstrictive peptide. Transcript variants that encode different protein isoforms and that arise from alternative splicing and the use of alternative promoters have been described, but their full-length nature has not been determined. Mutations in this gene have been shown to cause hyperuricemic nephropathy familial juvenile 2, familial hyperproreninemia, and renal tubular dysgenesis. [provided by RefSeq, May 2020]
REN Gene-Disease associations (from GenCC):
  • familial juvenile hyperuricemic nephropathy type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen
  • renal tubular dysgenesis of genetic origin
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 1-204160543-A-C is Benign according to our data. Variant chr1-204160543-A-C is described in ClinVar as Benign. ClinVar VariationId is 256380.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.4 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RENNM_000537.4 linkc.492+17T>G intron_variant Intron 4 of 9 ENST00000272190.9 NP_000528.1 P00797-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RENENST00000272190.9 linkc.492+17T>G intron_variant Intron 4 of 9 1 NM_000537.4 ENSP00000272190.8 P00797-1
RENENST00000638118.1 linkc.378+17T>G intron_variant Intron 6 of 11 5 ENSP00000490307.1 A0A1B0GUZ2

Frequencies

GnomAD3 genomes
AF:
0.250
AC:
38059
AN:
152066
Hom.:
4943
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.272
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.227
Gnomad EAS
AF:
0.414
Gnomad SAS
AF:
0.217
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.250
Gnomad NFE
AF:
0.231
Gnomad OTH
AF:
0.251
GnomAD2 exomes
AF:
0.253
AC:
63441
AN:
251134
AF XY:
0.249
show subpopulations
Gnomad AFR exome
AF:
0.267
Gnomad AMR exome
AF:
0.262
Gnomad ASJ exome
AF:
0.228
Gnomad EAS exome
AF:
0.423
Gnomad FIN exome
AF:
0.234
Gnomad NFE exome
AF:
0.234
Gnomad OTH exome
AF:
0.260
GnomAD4 exome
AF:
0.238
AC:
336155
AN:
1412478
Hom.:
41226
Cov.:
26
AF XY:
0.237
AC XY:
167001
AN XY:
705858
show subpopulations
African (AFR)
AF:
0.271
AC:
8818
AN:
32516
American (AMR)
AF:
0.263
AC:
11742
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.229
AC:
5911
AN:
25820
East Asian (EAS)
AF:
0.417
AC:
16466
AN:
39452
South Asian (SAS)
AF:
0.220
AC:
18774
AN:
85252
European-Finnish (FIN)
AF:
0.238
AC:
12691
AN:
53378
Middle Eastern (MID)
AF:
0.254
AC:
1442
AN:
5684
European-Non Finnish (NFE)
AF:
0.230
AC:
245838
AN:
1066942
Other (OTH)
AF:
0.246
AC:
14473
AN:
58788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
12948
25895
38843
51790
64738
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8478
16956
25434
33912
42390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.250
AC:
38086
AN:
152186
Hom.:
4947
Cov.:
32
AF XY:
0.250
AC XY:
18584
AN XY:
74422
show subpopulations
African (AFR)
AF:
0.272
AC:
11297
AN:
41516
American (AMR)
AF:
0.249
AC:
3809
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
787
AN:
3468
East Asian (EAS)
AF:
0.415
AC:
2147
AN:
5178
South Asian (SAS)
AF:
0.217
AC:
1046
AN:
4828
European-Finnish (FIN)
AF:
0.232
AC:
2460
AN:
10606
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.231
AC:
15693
AN:
67982
Other (OTH)
AF:
0.250
AC:
529
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1468
2936
4405
5873
7341
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.225
Hom.:
5156
Bravo
AF:
0.253
Asia WGS
AF:
0.292
AC:
1013
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 18192836) -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kidney disorder Benign:1
Dec 12, 2016
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial juvenile hyperuricemic nephropathy type 2 Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal tubular dysgenesis Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
6.8
DANN
Benign
0.38
PhyloP100
0.052
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5707; hg19: chr1-204129671; COSMIC: COSV107237342; API